Early Response to Everolimus Therapy Detected on Ga-68-DOTATATE PET/CT in a Patient With Pancreatic Neuroendocrine Tumor
CLINICAL NUCLEAR MEDICINE, cilt.41, sa.7, ss.561-563, 2016 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Editöre Mektup
- Cilt numarası: 41 Sayı: 7
- Basım Tarihi: 2016
- Doi Numarası: 10.1097/rlu.0000000000001242
- Dergi Adı: CLINICAL NUCLEAR MEDICINE
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.561-563
- Anahtar Kelimeler: Ga-68-DOTATATE PET/CT, everolimus, treatment response, RADIONUCLIDE THERAPY
- Ondokuz Mayıs Üniversitesi Adresli: Evet
Özet
Everolimus is a mammalian target of rapamycin inhibitor that has been recently approved for the treatment of patients with advanced progressive pancreatic neuroendocrine tumor. Here, we present a case in which an early therapy response to everolimus was effectively demonstrated by Ga-68-DOTATATE PET/CT.